This ones a heck of a specualive investment but it seems that the institutions are willing to stomp up the cash to back it in the long term.

Heres the latest news from Killik stocbrokers on the company..........

MEDICAL MARKETING Joint Venture

We recently highlighted Medical Marketing (MMG) as worthy of attention. The company, in which I have a personal share holding, has this morning announced the formation of a joint venture, Genvax, to develop a novel DNA vaccine platform technology.

Human trials have been underway since 2001 in areas such as Lymphoma and Myeloma but the technology has broad applications in cancer, viral and bacterial infections (hence the term platform). The technology works on boosting the immune system by teaching it to identify hard to recognise cancer proteins as foreign and destroy them. Early results from the 25 patient trial in lymphoma are encouraging and evaluation of the result is expected by March 2005. Successful results should mean big pharmaceutical groups will start to take financial and commercial interests around that time.

This looks to be the first of a series of announcements due from Medical Marketing as it has a range of predominantly cancer trials moving into the clinical stage. (news flow could push the price higher)

The stock has made good progress in recent sessions up to the mid-80p level where the company is valued at just under 40 million. ENDS.

Please DYOR

cheers GF.

Aren't you MMG holders deluding yourselves?
How can "any" AIM company be worth 3 a share? Other than if they have loads of cash - what is supporting this valuation?

I know there is lots of hope-value and people are saying great things about MMG treatments - but there's a need for caution - are these bankable treatments? Will anyone put a cash-value on them? (IMHO Not until they have been through rigourous trials - which will rely upon more "shareholder" cash being introduced.).... That causes dilution, so today's slice of the company (that cost you nearly 3) is later valued as a half-share (making a whole share closer to 6) - and you still want to invest at today's prices?

No, I don't see it either.

Gone quite looks like this could be the bottom.

hangon - sobering comments.

Thank you for your opinion.

GF. What have u got to say to hangon?

hangon should do his home work.

MS

Hangon, doesnt realise the company is awaiting one of the big boys to come in and buy up a 'sum of the parts'. I agree at this time in the companys growth cycle it is very difficult to put a valuation on a company like this. Perhaphs Mike Walters summed it up best in this piece..........

Just look at this from the Mike Walters site....................

Michael Walters tipping it again today, he himself bought more this morning. He ends his piece by saying, 'There could be much more to come as the world wakes up to the achievements of Dr Stevenson and her team.' - I must admit the announcement was too good for me to ignore and I have bought some MMG today also. I think we will all be looking very, very good on this stock in a small time. Cancer is such a huge killer and although there are many companies that have made big advances, the one recently announced by this company seems to have attracted not only investors attention but apparently, the attention of some major pharmaceutical companies. Licencing revenues from some of its drugs could bring in multpiles of the current market price on an annual basis. Is the pie in the sky stuff? Absolutely, but there is so much going on here and Im pretty sure we will see further news releases and updates, I just had to take a few for myself. I think this one is going to run and run. ENDS.

cheers GF.

Why should he? Good to have opinion on these threads, makes you examine your own thoughts. I too am a great believer in MMG but this has risen so sharply in recent months can the Genvax trials alone sustain 300p? We all expect the Ruthenium trials to be successful but you can't blame people for taking profits, I sold some more this morning and banked the profit. 200% profit is just too good to lose and is only a profit when taken. GF tells you that this is a high beta stock, always likely to fly on good news and fall back in between as it is still a highly speculative stock although a very good one. Don't be surprised if you get the chance to get back in at around 200-220p in a few weeks. I do believe 300p+ and alot more but need more news first so all points are valid.

gold finger, what was the date of MW's tip you quoted?

I see the Universities Superannuation scheme has also taken some profits.
They have been building up their holding for some time but again a profit is only a profit once realised. They too are sticking with it for the long-term but might as well take some profits for their beneficiaries. I am please to have taken 200% profit and will be back-in again once it has settled.

What we have got is panic selling from all the speculators on board. I raised this point last week when I said I didnt feel very easy with all the adfvn team jumping aboard. I saw the broker note on the online newspaper article refering to the valuation ? of MMG this weekend and I have to say there was nothing concrete in it whatsoever. The article was very vague and did not take into account the massive potential of the other MMG trials coming to market.

Lets face it we have Mike Walters, Killik Brokers, the house broker a whole raft of financial analysts and the financial press tipping this one for great things, but yet we get one solitary Broker who to me as judged this one completley wrong, and what do we get........... panic stations. Whats changed other than the date since last thursday, NOTHING. And thats why I for one will not be panicked out and in fact will add to my previous 3 purchases this morning.

Come 6 months time Im pretty confident Ill be holding the cash and shed loads of it.

cheers GF.

I got this from the other place.

I can remember when Glaxo were testing Zantac, many years ago. The trial results were so outstanding that it soon became obvious, to the astute, that this would transform the fortunes of the company and so it did.
We also all know that only a very small proportion of new drugs make it to market and even fewer become blockbusters but these are the companies that we are looking for.
Most phase 2 trials report only a small statistically significant improvement in the condition of the patient. This can often be only slightly better than the placebo but every now and again a trial comes up with results so outstanding that it can hardly fail to get to market and be a company maker.
You only have to look at the reported results here to realise that Genvax could be a huge winner for MMG.

1. The trial was with 25 patients all of them in a bad way with cancer and only a year or two life expectancy. 18 of the 25 are in remission and, according to Mike Walters, appear to be showing no signs of cancer.

2. Perhaps the clearest sign, half would be expected to be dead by now. In fact every patient in the trial is still alive.

3. Side effects are negligible.

4. The researches believe that this success could be replicated in a number of other types of cancer.

If this is all true (or even half true) it will transform MMG, for sure.
And yet relatively few people know about it. It has been reported to a conference but it has not yet even been reported in the newspapers. Not even the specialist share magazines have picked it up yet. People investing now have imo an opportunity to get in early on something that COULD turn out to be sensational. These chances are rare. Don't miss it, especially after today's pull back.
Xylos

Agreed gf, but I can already buy below the price I sold for and have time to see what direction this takes over the next few weeks before buying again.
We know the long-term direction of this but short-termers may drive this back down taking their profits.

I take your point andy and thanks for the above post re- to just how the trials went, but I have such confidence in these why should I sell and then buy back incurring all the costs. I did sell a couple of tranches before the results to make sure I had locked in profits, but to sell now would be sheer folly I feel. In fact Im just going to load up with them.

cheers GF.

Fully invested so can't take advantage.

MS

The Ruthenium news I'm told is positive and could be announced within a few weeks and the sp will climb up strongly so I would say shorters beware.

Well you have called it correct Mitzy everytime and always on time, Im not going to ask you where you get your info from but good on you for now moving onto the next big thing, yes the Ruthenium News is what we have to look forward to and it could be very positive again.

Looks like a lot of stop losses triggered today, hoping for a late surge of buyers at this cheap price.

cheers GF

What a rotten day all round. Those that got triggered out of this I think will buy back in tomorrow.

cheers GF.

We have has a great run recently gf and had a great update Genvax last week so I suppose profit taking was bound to happen sooner than later.News about ruthenium going in phase 2 trials is due soon accompanied by some even better news..hold on it could be about to turn up quicker than people realise..

I topped up this morning At 274. Still bullish and holding.
But I will confess my reaction on seeing the closing price on arriving home today.
For those of you who watch the 'fast show':

'OH BUGGER'

I was in @295p, and thinking to top up more tomorrow. It is interesting me that the price was holding @250 from 11:32am till end, such a long period, seems to me it is the bottom. Is that meant most buyers set their stop loss at the price 250p? I am still learning, so my Q may be silly, thanks for your patients.